VISTAGEN THERAPEUTICS, INC. Convertible Debt, Current
VISTAGEN THERAPEUTICS, INC. (VTGN) had Convertible Debt, Current of $352.60 thousand as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2020-11-12
- 2020-09-30: Convertible Debt, Current $352.60K.
- 2020-06-30: Convertible Debt, Current $100.10K.
- 2020-03-31: Convertible Debt, Current $0.00.
- 2017-12-31: Convertible Debt, Current $43.70K.
| Period end | Convertible Debt, Current |
|---|---|
| 2020-09-30 | $352.60K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $100.10K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $0.00 10-Q · filed 2020-11-12 |
| 2017-12-31 | $43.70K 10-Q · filed 2018-02-12 |
| 2017-03-31 | $54.80K 10-Q · filed 2018-02-12 |
| 2016-12-31 | $35.80K 10-Q · filed 2017-02-13 |
| 2016-06-30 | $105.90K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $43.60K 10-Q · filed 2017-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |